Managing Diabetes with Insulin Glargine U300
In this video, Dr. Banshi Saboo will be sharing invaluable insights into the efficacy and safety of Insulin Glargine U300 across various patient profiles, including its suitability during pregnancy for effective diabetes management. For any chosen drug, efficacy and safety are paramount. Insulin Glargine U300 is particularly beneficial for patients with uncontrolled diabetes, those on multiple oral anti-diabetic agents, patients with chronic kidney disease (CKD), the elderly, high-risk individuals for hypoglycaemia, and those with high glycaemic variability. Its unique mode of action reduces day-to-day glycaemic fluctuations, ensuring more stable blood glucose levels.
Insulin Glargine U300 can be safely used during pregnancy when clinically indicated. It offers a dosing flexibility of ±3 hours, providing convenience for patients who may not adhere to strict timing. Additionally, it requires a smaller injection volume, reducing pain and enhancing patient comfort. The Toustar device with a dedicated cartridge simplifies use, making it a user-friendly and smooth-operating option for patients.
Hello dear friends, I am Dr. Banshi Saboo, Diabetologist, Besset and Dabat. As we all know that for any drug which we choose for our patients, what about efficacy and safety of the drug of this new insulin? Is it convenient to use for patients? Whether the last, which is also very important, is it cost effective? A very important point is efficacy and safety. Whether they are uncontrolled or multiple oral and taryotic agents, whether they are patient with CKD, they are elderly, some of them are high risk for hypoglycemia and even their glycemic variability is high. Due to its unique mode of action, Glargin 300 benefits the patient with low day to day glycemic variability. Glargin 300 can be safely used in pregnancy if clinically indicated. The most important thing is a convenience. A dosing flexibility of plus minus 3R, that is very very important. When we say our patients that once in 24 hours, they may not take at the same time. This flexibility is there with Glargin 300. The second very important thing is less insulin volume, the less volume and less pain. Cost is an important issue when we are treating the every patient with a newer basal insulin, but I will say it is really economical, but it is second generation. If I compare it with other second generation insulin, it is 35% economical than other second generation. Device like toaster with dedicated cartridge benefit makes the users less confusing and very smooth to operate also. Thank you.
